Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants
Completed · Phase 2 · Has a placebo group
Conditions studied: Ureaplasma Infections
In brief
The purpose of this study is to determine whether intravenous azithromycin is effective in eradicating Ureaplasma respiratory tract infection in preterm infants born at 24 to 28 weeks gestation.
Key facts
- Study ID
- NCT01778634
- Run by
- University of Maryland, Baltimore
- People needed
- 121
- Starts
- 2013-07-01
- Expected to finish
- 2020-11-03
- Last updated by the study team
- 2020-11-30
Who can join
Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Gestational age 24 weeks 0 days-28weeks 6 days by best obstetrical estimate
- <72 h age
- Positive pressure ventilation for at least 1 hour duration during the first 72 hours of life
- Presence of indwelling intravenous line for drug administration
You may not qualify if…
- Any patient judged to be non-viable or for whom withdrawal of life support is planned
- Patients with major lethal congenital anomalies
- Triplets or higher order multiples
- Patients delivered for maternal indications (low risk of Ureaplasma colonization)
- Patients with EKG QT interval corrected for heart rate (Qtc) ≥ 450 ms
- Patients with significant hepatic impairment (direct bilirubin >1.5 mg/dL)
- Patients exposed to other systemic macrolide
- Patients with clinically suspected Ureaplasma central nervous system (CNS) infection or other confirmed bacterial/viral infection
- Patients participating in other clinical trials involving investigational products.
Where it is running
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- Christiana Care Health Services — Newark, Delaware, United States
- University of Maryland School of Medicine — Baltimore, Maryland, United States
- Mercy Medical Center — Baltimore, Maryland, United States
- Johns Hopkins University — Baltimore, Maryland, United States
- Monroe Carell Jr. Children's Hospital at Vanderbilt — Nashville, Tennessee, United States
- University of Virginia — Charlottesville, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.